PortfoliosLab logo
FAT vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between FAT and LLY is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

FAT vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in FAT Brands Inc. (FAT) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

FAT:

68.00%

LLY:

38.01%

Max Drawdown

FAT:

-4.51%

LLY:

-68.27%

Current Drawdown

FAT:

-4.51%

LLY:

-23.23%

Fundamentals

Market Cap

FAT:

$49.13M

LLY:

$659.45B

EPS

FAT:

-$11.60

LLY:

$12.27

PS Ratio

FAT:

0.08

LLY:

13.46

PB Ratio

FAT:

12.81

LLY:

41.83

Total Revenue (TTM)

FAT:

$440.69M

LLY:

$49.00B

Gross Profit (TTM)

FAT:

$114.50M

LLY:

$40.03B

EBITDA (TTM)

FAT:

-$22.27M

LLY:

$16.67B

Returns By Period


FAT

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

LLY

YTD

-4.68%

1M

0.29%

6M

-11.36%

1Y

-2.72%

5Y*

37.88%

10Y*

28.33%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

FAT vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FAT
The Risk-Adjusted Performance Rank of FAT is 2626
Overall Rank
The Sharpe Ratio Rank of FAT is 2727
Sharpe Ratio Rank
The Sortino Ratio Rank of FAT is 2929
Sortino Ratio Rank
The Omega Ratio Rank of FAT is 2727
Omega Ratio Rank
The Calmar Ratio Rank of FAT is 2222
Calmar Ratio Rank
The Martin Ratio Rank of FAT is 2626
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 4141
Overall Rank
The Sharpe Ratio Rank of LLY is 4747
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 3939
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 3939
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 3939
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 4343
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FAT vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for FAT Brands Inc. (FAT) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

FAT vs. LLY - Dividend Comparison

FAT's dividend yield for the trailing twelve months is around 8.51%, more than LLY's 0.74% yield.


TTM20242023202220212020201920182017201620152014
FAT
FAT Brands Inc.
8.51%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.74%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

FAT vs. LLY - Drawdown Comparison

The maximum FAT drawdown since its inception was -4.51%, smaller than the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for FAT and LLY. For additional features, visit the drawdowns tool.


Loading data...

Volatility

FAT vs. LLY - Volatility Comparison


Loading data...

Financials

FAT vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between FAT Brands Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B14.00B20212022202320242025
145.28M
12.73B
(FAT) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

FAT vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between FAT Brands Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20212022202320242025
25.0%
82.5%
(FAT) Gross Margin
(LLY) Gross Margin
FAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, FAT Brands Inc. reported a gross profit of 36.28M and revenue of 145.28M. Therefore, the gross margin over that period was 25.0%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.

FAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, FAT Brands Inc. reported an operating income of -39.30M and revenue of 145.28M, resulting in an operating margin of -27.1%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.

FAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, FAT Brands Inc. reported a net income of -67.42M and revenue of 145.28M, resulting in a net margin of -46.4%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.